FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Glaspy

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Living Beings

Procedures

Immunotherapy

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Antoni Ribas; Erjian Wang; Amy P Abernethy; Jason A Chesney; Bartosz Chmielowksi; Diana Gerhardt; John A Glaspy; Jesus Gomez-Navarro; Michael S Gordon; Poe-Hirr Hsyu; Bo Huang; David H Lawson; Karl Lewis; Theodore F Logan; Margaret A Marshall; Rene Gonzalez
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion.
John A Glaspy
Darbepoetin alfa controversies, from dosage issues to safety concerns: the larger lesson.
Franziska Niehr; Juan Recio; Hooman Sazegar; Erika von Euw; Narsis Attar; Begoña Comin-Anduix; John A Glaspy; Deliang Guo; Roger S Lo; Doug Matsunaga; Paul S Mischel; Charles Ng; Antoni Ribas
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Glaspy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Antoni Ribas; Erjian Wang; Amy P Abernethy; Jason A Chesney; Bartosz Chmielowksi; Diana Gerhardt; John A Glaspy; Jesus Gomez-Navarro; Michael S Gordon; Poe-Hirr Hsyu; Bo Huang; David H Lawson; Karl Lewis; Theodore F Logan; Margaret A Marshall; Rene Gonzalez
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion.
Journal of translational medicine 2012;10():236.
2011: John A Glaspy
Darbepoetin alfa controversies, from dosage issues to safety concerns: the larger lesson.
Oncology (Williston Park, N.Y.) 2011;25(5):423-4.
2011: Franziska Niehr; Juan Recio; Hooman Sazegar; Erika von Euw; Narsis Attar; Begoña Comin-Anduix; John A Glaspy; Deliang Guo; Roger S Lo; Doug Matsunaga; Paul S Mischel; Charles Ng; Antoni Ribas
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations.
Journal of translational medicine 2011;9():76.
2011: John A Glaspy
Randomized controlled trials of the erythroid-stimulating agents in cancer patients.
Cancer treatment and research 2011;157():195-215.
2010: William D Tap; Ke-Wei Gong; Judy Dering; Yiou Tseng; Charles Ginther; Giovanni Pauletti; John A Glaspy; Richard Essner; Gideon Bollag; Peter Hirth; Chao Zhang; Dennis J Slamon
Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.
Neoplasia (New York, N.Y.) 2010;12(8):637-49.
2010: Antoni Ribas; Luis H Camacho; Sun Min Lee; Evan M Hersh; Charles K Brown; Jon M Richards; Maria Jovie Rodriguez; Victor G Prieto; John A Glaspy; Denise K Oseguera; Jackie Hernandez; Arturo Villanueva; Bartosz Chmielowski; Peggie Mitsky; Nadège Bercovici; Ernesto Wasserman; Didier Landais; Merrick I Ross
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.
Journal of translational medicine 2010;8():89.
2009: Antoni Ribas; Bartosz Chmielowski; John A Glaspy
Do we need a different set of response assessment criteria for tumor immunotherapy?
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7116-8.
2009: Antoni Ribas; Begoña Comin-Anduix; Bartosz Chmielowski; Jason Jalil; Pilar de la Rocha; Tara A McCannel; Maria Teresa Ochoa; Elisabeth Seja; Arturo Villanueva; Denise K Oseguera; Bradley R Straatsma; Alistair J Cochran; John A Glaspy; Liu Hui; Francesco M Marincola; Ena Wang; James S Economou; Jesus Gomez-Navarro
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6267-76.
2009: John A Glaspy; Veena Charu; Donghan Luo; Victor Moyo; Marc Kamin; Francois E Wilhelm
Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy: an open-label, multicenter study with randomized and nonrandomized treatment arms.
Cancer 2009;115(5):1121-31.
2009: Antoni Ribas; Begoña Comin-Anduix; James S Economou; Timothy R Donahue; Pilar de la Rocha; Lilah F Morris; Jason Jalil; Vivian B Dissette; I Peter Shintaku; John A Glaspy; Jesus Gomez-Navarro; Alistair J Cochran
Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):390-9.
2009: John A Glaspy
Erythropoietin in cancer patients.
Annual review of medicine 2009;60():181-92.
2008: John A Glaspy
Erythropoiesis-stimulating agents in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(6):565-75.
2008: Lisa H Butterfield; Begonya Comin-Anduix; Lazar Vujanovic; Yohan Lee; Vivian B Dissette; Jin-Quan Yang; Hong T Vu; Elisabeth Seja; Denise K Oseguera; Douglas M Potter; John A Glaspy; James S Economou; Antoni Ribas
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(3):294-309.
2008: Begoña Comin-Anduix; Yohan Lee; Jason Jalil; Alain Algazi; Pilar de la Rocha; Luis H Camacho; Viviana A Bozon; Cecile A Bulanhagui; Elisabeth Seja; Arturo Villanueva; Bradley R Straatsma; Antonio Gualberto; James S Economou; John A Glaspy; Jesus Gomez-Navarro; Antoni Ribas
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
Journal of translational medicine 2008;6():22.
2007: Bradley R Straatsma; Steven Nusinowitz; Tara A Young; Lynn K Gordon; Melissa W Chun; Colleen Rosen; Elisabeth Seja; James S Economou; John A Glaspy; Viviana Bozon; Jesus Gomez-Navarro; Antoni Ribas
Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
American journal of ophthalmology 2007;143(6):958-969.
2006: Naoko Kobayashi; R James Barnard; Susanne M Henning; David Elashoff; Srinivasa T Reddy; Pinchas Cohen; Pak Leung; Jenny Hong-Gonzalez; Stephen J Freedland; Jonathan Said; Dorina Gui; Navindra P Seeram; Laura M Popoviciu; Dilprit Bagga; David Heber; John A Glaspy; William J Aronson
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4662-70.
2006: Antoni Ribas; Dan D Vo; David L Weeks; Begoña Comin-Anduix; Lana Y Schumacher; Hermes Garban; Colin McLean; Jinquan Yang; Vivian B Dissette; Pedro Peraza; Sharla K Owens; william mcbride; John A Glaspy; James S Economou
Broad antitumor protection by dendritic cells administered to CD8alpha knock out mice.
Cancer immunology, immunotherapy : CII 2006;55(6):663-71.
2006: Lisa H Butterfield; Antoni Ribas; Vivian B Dissette; Yohan Lee; Jin Quan Yang; Pilar De la Rocha; Sonia D Duran; Jackie Hernandez; Elisabeth Seja; Douglas M Potter; william mcbride; Richard Finn; John A Glaspy; James S Economou
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2817-25.
2006: Lana Y Schumacher; Dan D Vo; Hermes Garban; Begoña Comin-Anduix; Sharla K Owens; Vivian B Dissette; John A Glaspy; william mcbride; Benjamin Bonavida; James S Economou; Antoni Ribas
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade).
Journal of immunology (Baltimore, Md. : 1950) 2006;176(8):4757-65.
2006: Begoña Comin-Anduix; Antonio Gualberto; John A Glaspy; Elisabeth Seja; Maribel Ontiveros; Deborah L Reardon; Roberto Renteria; Brigitte Englahner; James S Economou; Jesus Gomez-Navarro; Antoni Ribas
Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):107-16.
2005: Antoni Ribas; Luis H Camacho; Gabriel Lopez-Berestein; Dmitri Pavlov; Cecile A Bulanhagui; Robert Millham; Begoña Comin-Anduix; James M Reuben; Elisabeth Seja; Charla A Parker; Amarnath Sharma; John A Glaspy; Jesus Gomez-Navarro
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(35):8968-77.
2005: John A Glaspy
Cancer patient survival and erythropoietin.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(6):796-804.
2005: John A Glaspy
Every-three-week erythropoietic support during chemotherapy for cancer: current status and future issues.
Supportive cancer therapy 2005;3(1):16-20.
2005: John A Glaspy
The development of erythropoietic agents in oncology.
Expert opinion on emerging drugs 2005;10(3):553-67.
2005: Jennifer A Wargo; Lana Y Schumacher; Begoña Comin-Anduix; Vivian B Dissette; John A Glaspy; william mcbride; Lisa H Butterfield; James S Economou; Antoni Ribas
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells.
Cancer gene therapy 2005;12(6):516-27.
2005: Hilda Chamras; Sanford H Barsky; Ani Ardashian; Daniel Navasartian; David Heber; John A Glaspy
Novel interactions of vitamin E and estrogen in breast cancer.
Nutrition and cancer 2005;52(1):43-8.
2005: John A Glaspy
Entering a new era in the management of tumor-associated involution.
The journal of supportive oncology 2005;3(1):51-2.
2004: Antoni Ribas; John A Glaspy; Yohan Lee; Vivian B Dissette; Elisabeth Seja; Huong T Vu; N Simon Tchekmedyian; Denise Oseguera; Begoña Comin-Anduix; Jennifer A Wargo; Saral N Amarnani; william mcbride; James S Economou; Lisa H Butterfield
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(5):354-67.
2004: Lynn K Gordon; Antoni Ribas; Steven Nusinowitz; Lisa H Butterfield; John A Glaspy; James S Economou; Bradley R Straatsma
Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma.
Controlled clinical trials 2004;25(4):400-7.
2004: Antoni Ribas; Jennifer A Wargo; Begoña Comin-Anduix; Shelley Sanetti; Lana Y Schumacher; Colin McLean; Vivian B Dissette; John A Glaspy; william mcbride; Lisa H Butterfield; James S Economou
Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(8):4762-9.
2003: John A Glaspy
Hematopoietic management in oncology practice. Part 2. Erythropoietic factors.
Oncology (Williston Park, N.Y.) 2003;17(12):1724-30; discussion 1731-2, 1735, 1739.
2003: Lisa H Butterfield; Antoni Ribas; Wilson S Meng; Vivian B Dissette; Saral N Amarnani; Huong T Vu; Elisabeth Seja; Karen Todd; John A Glaspy; william mcbride; James S Economou
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5902-8.
2003: John A Glaspy
Hematopoietic management in oncology practice. Part 1. Myeloid growth factors.
Oncology (Williston Park, N.Y.) 2003;17(11):1593-603.
2003: Antoni Ribas; Lisa H Butterfield; John A Glaspy; James S Economou
Current developments in cancer vaccines and cellular immunotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2415-32.
2003: Lisa H Butterfield; Antoni Ribas; Vivian B Dissette; Saral N Amarnani; Huong T Vu; Denise Oseguera; He-Jing Wang; Robert Elashoff; william mcbride; Bijay Mukherji; Alistair J Cochran; John A Glaspy; James S Economou
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):998-1008.
2003: John A Glaspy; Jaswant Sinh Jadeja; Glen Justice; Alex Fleishman; Gregory Rossi; Alan B Colowick
A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
Cancer 2003;97(5):1312-20.
2003: Dilprit Bagga; Ling Wang; Robin Farias-Eisner; John A Glaspy; Srinivasa T Reddy
Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(4):1751-6.
2002: Antoni Ribas; Saral N Amarnani; Georgette M Buga; Lisa H Butterfield; Vivian B Dissette; william mcbride; John A Glaspy; Louis J Ignarro; James S Economou
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines.
Cancer gene therapy 2002;9(11):875-83.
2002: John A Glaspy; N Simon Tchekmedyian
Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapy.
Oncology (Williston Park, N.Y.) 2002;16(10 Suppl 11):23-9.
2002: John A Glaspy
Overcoming barriers to erythropoietic therapy. Characteristics of darbepoetin alfa and potential advances in scheduling, dosing, and dose-efficiency.
Oncology (Williston Park, N.Y.) 2002;16(9 Suppl 10):71-7.
2002: John A Glaspy
The potential for anemia treatment to improve survival in cancer patients.
Oncology (Williston Park, N.Y.) 2002;16(9 Suppl 10):35-40.
2002: Ronald L Paquette; NC Hsu; Jonathan Said; M Mohammed; Nagesh P Rao; G Shih; Gary J Schiller; Charles L Sawyers; John A Glaspy
Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
Leukemia 2002;16(8):1484-9.
2002: John A Glaspy; Jaswant Sinh Jadeja; Glen Justice; J Kessler; D Richards; L Schwartzberg; N Simon Tchekmedyian; S Armstrong; J O'Byrne; Gregory Rossi; Alan B Colowick
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy.
British journal of cancer 2002;87(3):268-76.
2002: John A Glaspy
Therapeutic options in the management of renal cell carcinoma.
Seminars in oncology 2002;29(3 Suppl 7):41-6.
2002: Ronald L Paquette; Sanaa T Dergham; Ellen Karpf; He-Jing Wang; Dennis J Slamon; Larry Souza; John A Glaspy
Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery.
Experimental hematology 2002;30(4):374-80.
2002: Antoni Ribas; Lisa H Butterfield; John A Glaspy; James S Economou
Cancer immunotherapy using gene-modified dendritic cells.
Current gene therapy 2002;2(1):57-78.
2002: Dilprit Bagga; Karl H Anders; He-Jing Wang; John A Glaspy
Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer.
Nutrition and cancer 2002;42(2):180-5.
2001: Antoni Ribas; Lisa H Butterfield; Saral N Amarnani; Vivian B Dissette; D Kim; Wilson S Meng; G A Miranda; He-Jing Wang; william mcbride; John A Glaspy; James S Economou
CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
Cancer research 2001;61(24):8787-93.
2001: Wilson S Meng; Lisa H Butterfield; Antoni Ribas; Vivian B Dissette; Justin B Heller; G A Miranda; John A Glaspy; william mcbride; James S Economou
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.
Cancer research 2001;61(24):8782-6.
2001: William J Aronson; John A Glaspy; Srinivasa T Reddy; DM Reese; David Heber; Dilprit Bagga
Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer.
Urology 2001;58(2):283-8.
2001: Lisa H Butterfield; Wilson S Meng; A Koh; CM Vollmer; Antoni Ribas; Vivian B Dissette; K Faull; John A Glaspy; william mcbride; James S Economou
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(8):5300-8.
2000: Kahlil J Andrews; Antoni Ribas; Lisa H Butterfield; CM Vollmer; Fritz C Eilber; Vivian B Dissette; Scott D Nelson; P Shintaku; S Mekhoubad; T Nakayama; M Taniguchi; John A Glaspy; william mcbride; James S Economou
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Cancer research 2000;60(22):6457-64.
2000: Wilson S Meng; Lisa H Butterfield; Antoni Ribas; Justin B Heller; Vivian B Dissette; John A Glaspy; william mcbride; James S Economou
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein.
Molecular immunology 2000;37(16):943-50.
2000: Ronald L Paquette; S T Dergham; E Karpf; H J Wang; Dennis J Slamon; L Souza; John A Glaspy
Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer.
Blood 2000;96(7):2385-90.
2000: John A Glaspy
Hematologic supportive care of the critically ill cancer patient.
Seminars in oncology 2000;27(3):375-83.
2000: Dilprit Bagga; K H Anders; He-Jing Wang; E Roberts; John A Glaspy
Organochlorine pesticide content of breast adipose tissue from women with breast cancer and control subjects.
Journal of the National Cancer Institute 2000;92(9):750-3.
2000: Antoni Ribas; Lisa H Butterfield; B Hu; Vivian B Dissette; Wilson S Meng; A Koh; Kahlil J Andrews; M Lee; S N Amar; John A Glaspy; william mcbride; James S Economou
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.
Cancer research 2000;60(8):2218-24.
2000: Antoni Ribas; Lisa H Butterfield; B Hu; Vivian B Dissette; AY Chen; A Koh; Saral N Amarnani; John A Glaspy; william mcbride; James S Economou
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(1):59-66.
1999: Antoni Ribas; Lisa H Butterfield; william mcbride; Vivian B Dissette; A Koh; CM Vollmer; B Hu; AY Chen; John A Glaspy; James S Economou
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells.
Cancer gene therapy 1999;6(6):523-36.
1999: CM Vollmer; Antoni Ribas; Lisa H Butterfield; Vivian B Dissette; Kahlil J Andrews; Fritz C Eilber; L D Montejo; AY Chen; B Hu; John A Glaspy; william mcbride; James S Economou
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
Cancer research 1999;59(17):4369-74.
1999: Lisa H Butterfield; A Koh; W Meng; CM Vollmer; Antoni Ribas; Vivian B Dissette; E Lee; John A Glaspy; william mcbride; James S Economou
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
Cancer research 1999;59(13):3134-42.
1999: CM Vollmer; Fritz C Eilber; Lisa H Butterfield; Antoni Ribas; Vivian B Dissette; A Koh; L D Montejo; M C Lee; Kahlil J Andrews; william mcbride; John A Glaspy; James S Economou
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
Cancer research 1999;59(13):3064-7.
1999: John A Glaspy
Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy.
Bone marrow transplantation 1999;23 Suppl 2():S21-7.
1999: Elizabeth J Shpall; C A Wheeler; Stewart A Turner; Saul Yanovich; R A Brown; Andrew L Pecora; Thomas C Shea; K F Mangan; Stephanie F Williams; Charles F LeMaistre; G D Long; R Jones; M W Davis; R Murphy-Filkins; W R Parker; John A Glaspy
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.
Blood 1999;93(8):2491-501.
1999: Antoni Ribas; Lynne Bui; Lisa H Butterfield; CM Vollmer; Shahla M Jilani; Vivian B Dissette; John A Glaspy; william mcbride; James S Economou
Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities.
Anticancer research 1999;19(2A):1165-70.
1998: Lisa H Butterfield; Shahla M Jilani; Nitya G Chakraborty; Lynne Bui; Antoni Ribas; Vivian B Dissette; R Lau; S C Gamradt; John A Glaspy; william mcbride; Bijay Mukherji; James S Economou
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(10):5607-13.
1998: Shahla M Jilani; John A Glaspy
Impact of epoetin alfa in chemotherapy-associated anemia.
Seminars in oncology 1998;25(5):571-6.
1998: Ronald L Paquette; NC Hsu; Sylvia M Kiertscher; AN Park; L Tran; Michael D Roth; John A Glaspy
Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells.
Journal of leukocyte biology 1998;64(3):358-67.
1997: Lynne Bui; Lisa H Butterfield; J Y Kim; Antoni Ribas; Philip Seu; Roy Lau; John A Glaspy; william mcbride; James S Economou
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.
Human gene therapy 1997;8(18):2173-82.
1997: John A Glaspy; Elizabeth J Shpall; Charles F LeMaistre; Robert Briddell; Dora M Menchaca; Stewart A Turner; Michael Lill; LI Chap; R Jones; M D Wiers; William Patrick Sheridan; Ian K McNiece
Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
Blood 1997;90(8):2939-51.
1997: S L Capone; Dilprit Bagga; John A Glaspy
Relationship between omega-3 and omega-6 fatty acid ratios and breast cancer.
Nutrition (Burbank, Los Angeles County, Calif.) 1997;13(9):822-4.
1997: Dilprit Bagga; S Capone; He-Jing Wang; David Heber; Michael Lill; LI Chap; John A Glaspy
Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer.
Journal of the National Cancer Institute 1997;89(15):1123-31.
1997: Antoni Ribas; Lisa H Butterfield; william mcbride; Shahla M Jilani; Lynne Bui; CM Vollmer; R Lau; Vivian B Dissette; B Hu; AY Chen; John A Glaspy; James S Economou
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.
Cancer research 1997;57(14):2865-9.